Cortica

Veteran healthcare executive Trip Hofer joins .406 Ventures as Venture Partner

Retrieved on: 
Wednesday, November 15, 2023
Sale, Partner (business rank), Nursing care plan, UnitedHealth Group, CVS Health, Webster Bank, Health Dialog, U.S. Venture Partners, Communication, Trip, BUPA, Mental, Cortica, Health, Redox, Optum

BOSTON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- .406 Ventures , the 18 year-old Boston-based, early-stage venture capital firm focused on healthcare and enterprise technology, added Trip Hofer to its team as a Venture Partner in October.

Key Points: 
  • BOSTON, Nov. 15, 2023 (GLOBE NEWSWIRE) -- .406 Ventures , the 18 year-old Boston-based, early-stage venture capital firm focused on healthcare and enterprise technology, added Trip Hofer to its team as a Venture Partner in October.
  • Hofer brings unparalleled healthcare industry experience to .406.
  • .406 has been investing in disruptive healthcare companies for nearly two decades, backing category-defining companies in primary care, behavioral health, eldercare, and AI-driven healthcare data management.
  • “Working with Trip as an executive leader in our portfolio over the past 20 years has been both fun and successful” said Liam Donohue, Co-founder and Managing Partner of .406 Ventures.

LRVHealth Promotes Ellen Herlacher to Partner

Retrieved on: 
Tuesday, November 7, 2023
Health Insurance, Professional Services, Health, Finance, Tufts University, Goldman Sachs, Government, History, News, Bain & Company, Cortica, Digital, Free Enterprise Fund v. Public Company Accounting Oversight Board, Cornell University, Massachusetts Institute of Technology, Investment, Tufts Health Plan, CVS Health

LRVHealth , the inside healthcare venture capital platform, today announced the promotion of Ellen Herlacher from principal to partner.

Key Points: 
  • LRVHealth , the inside healthcare venture capital platform, today announced the promotion of Ellen Herlacher from principal to partner.
  • The firm most recently expanded its team by welcoming Josh Flum , former chief strategy officer of CVS Health, as managing partner in November 2022.
  • As partner at LRVHealth, Herlacher will co-lead the firm’s research and investments in new care delivery, behavioral health, workforce transformation, and government sponsored payers.
  • "LRVHealth's north star is, and has always been, to shape a healthcare system that is more effective, more accessible, more sustainable, and more humane," said Ellen Herlacher, partner at LRVHealth.

Questa Capital Closes $397M Fund III to Invest in Expansion Stage Healthcare Companies

Retrieved on: 
Thursday, August 24, 2023
Consultant, SAN, Brad, Founders Fund, Growth, Entrepreneurship, Fund, Environment, Safety, Financial services, Pharmaceutical industry, Asset management, Cortica

WASHINGTON and SAN FRANCISCO, Aug. 24, 2023 /PRNewswire/ -- Questa Capital Management, a venture growth equity firm exclusively dedicated to the healthcare industry, today announced the final close of Questa Capital Partners III, LP (the "Fund") with $397 million of capital commitments, bringing the firm's aggregate committed capital to more than $1 billion. The Fund will invest selectively in a portfolio of growth companies in three healthcare sectors of focus: services, technology, and medical devices. The firm has an investment team of ten led by Founder Ryan Drant and Managing Partners Brad Sloan and Shawn Conway, and currently manages eighteen portfolio companies across its three healthcare sectors.

Key Points: 
  • The Fund will invest selectively in a portfolio of growth companies in three healthcare sectors of focus: services, technology, and medical devices.
  • Questa Capital III will invest in growth companies in 3 healthcare sectors: services, technology and medical devices.
  • Questa Founder and Managing Partner Ryan Drant noted, "We are extremely pleased to close on Fund III despite a challenging fundraising environment.
  • We are honored to work closely with our portfolio companies, including marquee companies like Dispatch Health, Cortica, Medrio, and Calyxo.

EmpowerHealth is Improving Health, One Conversation at a Time

Retrieved on: 
Tuesday, June 13, 2023
Data Management, Health, Technology, Health Technology, Other Health, Software, General Health, Medicaid, Health education, Health equity, Intelligence, Human, Multimedia, Government, Organization, Medicare, Margaret Kelly, Hospital, Patient, UnitedHealth Group, Risk, Cortica, Optum, AI, Transport, Nursing

The company has nearly a decade of experience helping health providers and payers seamlessly support individuals in achieving better health outcomes through multi-modal conversation and augmented intelligence.

Key Points: 
  • The company has nearly a decade of experience helping health providers and payers seamlessly support individuals in achieving better health outcomes through multi-modal conversation and augmented intelligence.
  • View the full release here: https://www.businesswire.com/news/home/20230613580497/en/
    EmpowerHealth also announces the appointment of Margaret Kelly as chief growth officer.
  • A veteran of industry giants such as UnitedHealthcare and Optum, Kelly is an established leader in driving growth, sales strategy, customer retention, and team engagement.
  • (Photo: Business Wire)
    Medicaid redetermination, workforce shortages, and health equity are three of the toughest challenges facing health providers and payers across the country.

BLUE CROSS BLUE SHIELD OF MASSACHUSETTS' SPENDING ON MENTAL HEALTH SERVICES DOUBLED SINCE START OF PANDEMIC

Retrieved on: 
Monday, June 5, 2023
Yoga, ABA, Depression, Speech, Senior counsel, Anxiety, COVID-19, Blue Cross Blue Shield Association, Mindfulness, Spectrum, Occupational therapy, Insomnia, Patient, Mental, Cortica, Meditation, Headway, Mental health, Nursing, Pharmaceutical industry, State, Brightline, Blue Cross

BOSTON, June 5, 2023 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts' ("Blue Cross") annual spending on mental health services for its members has doubled since the start of the COVID-19 pandemic. In 2019, the company spent $610 million on mental health services, and new data just released finds that number doubled in 2022 to $1.3 billion. The increase in spending is attributed to more members seeking mental health care and substance use disorder treatment during the COVID-19 pandemic.

Key Points: 
  • State's leading health plan continues to expand provider network, virtual care options and mental health resources to meet growing member needs
    BOSTON, June 5, 2023 /PRNewswire/ -- Blue Cross Blue Shield of Massachusetts ' ("Blue Cross") annual spending on mental health services for its members has doubled since the start of the COVID-19 pandemic.
  • "Access to high-quality, convenient and affordable mental health care has never been more important," said Sarah Iselin, Blue Cross' president and CEO.
  • Blue Cross' mental health provider network has grown by 50% over the past five years, and now includes more than 18,000 clinicians.
  • Members who need assistance finding mental health and/or substance use support options can also call Blue Cross' dedicated mental health line at (888) 389-7764.

Cognyte Announces Appointment of Avi Cohen to Board of Directors

Retrieved on: 
Tuesday, May 9, 2023
Data Analytics, Security, Professional Services, Technology, Software, Orbital Technologies Commercial Space Station, Nova Measuring Instruments, RR Media, Avi Cohen, Cortica, Artificial intelligence, Management

Cognyte Software Ltd. (NASDAQ: CGNT), a global leader in investigative analytics software, today announced the appointment of Avi Cohen to the Cognyte Board of Directors, effective June 4, 2023.

Key Points: 
  • Cognyte Software Ltd. (NASDAQ: CGNT), a global leader in investigative analytics software, today announced the appointment of Avi Cohen to the Cognyte Board of Directors, effective June 4, 2023.
  • “We are pleased to welcome Avi Cohen to the Cognyte Board,” said Dan Bodner, chairman of Cognyte’s Board of Directors.
  • Previously, Mr. Cohen held executive roles leading a variety of technology companies.
  • Among others, he served as chief executive officer of RR Media Ltd. and president and chief executive officer of Orbit Technologies Ltd.
    “I’m excited to be joining the Cognyte board,” said Avi Cohen.

Point32Health and Cortica Team Up to Transform the Quality of Care for Children with Autism and Other Developmental Differences

Retrieved on: 
Thursday, September 22, 2022
Income, Health, Time, Centers for Disease Control and Prevention, Child, Center, Harvard Pilgrim Health Care, Neurology, Organization, Population, Tufts Health Plan, Industry, Health equity, Academic health science centre, Massachusetts health care reform, Medicaid, Physician, CEO, Goal, Leadership, Diagnosis, Autism, Insurance, Research, ABA, ASD, Multimedia, Health insurance, Management, Residential care, Medicine, MD, Cortica

CANTON, Mass., Sept. 22, 2022 /PRNewswire/ -- Point32Health, the parent company of Harvard Pilgrim Health Care and Tufts Health Plan, has joined forces with Cortica, a physician-led autism services provider, to expand access to advanced neurological therapies for children with autism spectrum disorder (ASD) and other developmental differences in Massachusetts. Tufts Health Plan members with insurance coverage through their employer or via the Massachusetts Health Connector will be able to access Cortica's pioneering integrated care model in September, followed by a rollout to the company's MassHealth and Harvard Pilgrim Health Care members later in the fall.

Key Points: 
  • Cortica's model has been scientifically proven to deliver superior developmental outcomes for children and families.
  • I commend their leadership for seeing the future of autism care and doing what's right for their members."
  • Point32Health is a leading health and wellbeing organization, delivering an ever-better health care experience to everyone in our communities.
  • Cortica is the first and only private, single point-of-care solution that delivers the entirety of autism services, all in one place.

Autism Impact Fund Makes Strategic Investment In Cortica

Retrieved on: 
Wednesday, April 20, 2022
Family, CEO, Metabolomics, Medicine, Genetics, Entrepreneurship, Lists of diseases, Data, National, SAN, Academic health science centre, Mental health, Technology, Neuroimaging, Phenotype, Standard of care, Ecosystem, Neurology, AIF, Cardiology, Physician, Autism, Time, Residential care, Pharmaceutical industry, Cortica

SAN DIEGO, April 20, 2022 /PRNewswire-PRWeb/ -- Cortica Inc. ("Cortica"), the leading physician-led, coordinated and tech-enabled care model focused on autism and other neurodiverse conditions, received a strategic investment by the Autism Impact Fund (AIF) which will further enable Cortica to bring its "whole-child" medical and behavioral care model to more families across the country. AIF's mission is to revolutionize the status quo for diagnosing, treating, and living with autism through a for-profit venture capital model, and Cortica is the tenth company in which AIF has invested.

Key Points: 
  • SAN DIEGO, April 20, 2022 /PRNewswire-PRWeb/ -- Cortica Inc. ("Cortica"), the leading physician-led, coordinated and tech-enabled care model focused on autism and other neurodiverse conditions, received a strategic investment by the Autism Impact Fund (AIF) which will further enable Cortica to bring its "whole-child" medical and behavioral care model to more families across the country.
  • AIF's mission is to revolutionize the status quo for diagnosing, treating, and living with autism through a for-profit venture capital model, and Cortica is the tenth company in which AIF has invested.
  • "Autism Impact Fund's strategic investment is an important validation of our mission to design and deliver life changing careone child, one family, one community at a time," added Dr. Hattangadi.
  • The Autism Impact Fund (AIF) seeks to become the investment and innovation arm of the autism community.

CORTICA ADDS TWO PROVEN INDUSTRY LEADERS TO DRIVE NATIONWIDE GROWTH AND VALUE-BASED CARE

Retrieved on: 
Wednesday, February 2, 2022
Growth, Landmark, CEO, Culture, Government, Patient, Learning, SAN, MinuteClinic, O'Rourke, Nature, Academic health science centre, Technology, Population, Multi-system (rail), NP-C, Margaret, Neurology, Optum, Autism, SVP, Health, Empowerment, UnitedHealth Group, Education, NICU, Life, COO, Senior, ED, CVS Health, MSN, Management, Medicine, Health insurance, United, Cortica

Kari O'Rourke, MSN, NP-C joins Cortica as Chief Operating Officer, and Margaret Kelly joins as Chief Growth Officer.

Key Points: 
  • Kari O'Rourke, MSN, NP-C joins Cortica as Chief Operating Officer, and Margaret Kelly joins as Chief Growth Officer.
  • Propelled by a Series C investment last year, Cortica opened new locations in California, Texas, Illinois, New Jersey, and New York, with additional states planned throughout this year.
  • As Chief Operating Officer, O'Rourke will scale Cortica's operations nationally, while continuing its focus on clinical excellence and a culture of learning and empowerment.
  • "Alongside the Cortica team, I'm excited to streamline the autism care journey for both providers and patients, bringing life-changing care to the neurodiverse community."

AutoBrains Revolutionary AI Central To Leading Supplier's ADAS and AV Growth Strategy

Retrieved on: 
Friday, June 11, 2021
Airlines, Applied machine learning, Cortica, Aviation, Advanced driver-assistance systems, Continental Airlines, ADAS, Economy of the United States

TEL AVIV, Israel, June 11, 2021 /PRNewswire/ --Israeli artificial intelligence startup, AutoBrains, today announced that its revolutionary unsupervised AI technology is at the center of leading Tier 1 supplier Continental's growth strategy in the advanced driver assistance system (ADAS) and autonomous vehicle (AV) market.

Key Points: 
  • TEL AVIV, Israel, June 11, 2021 /PRNewswire/ --Israeli artificial intelligence startup, AutoBrains, today announced that its revolutionary unsupervised AI technology is at the center of leading Tier 1 supplier Continental's growth strategy in the advanced driver assistance system (ADAS) and autonomous vehicle (AV) market.
  • AutoBrains revolutionary unsupervised AI technology is at the center of Continental's growth strategy in ADAS and AV.
  • AutoBrains is the creator of a novel AI for the automotive industry capable of overcoming the hardest challenges where current systems are plagued by barriers and will establish a faster technology trajectory for ADAS and AV systems.
  • AutoBrains emerged out of AI tech company, Cortica, after identifying the potential of the unsupervised learning technology to vastly improve AI for automotive.